Yuan Li, M.D.

Peking University People's Hospital
Beijing, Beijing, China (People's Republic)

Presentation(s):

• Paper 10 - TQB2928, A NOVEL ANTI-CD47 MONOCLONAL ANTIBODY, IN COMBINATION WITH ANLOTINIB FOR THE TREATMENT OF RECURRENT/METASTATIC OSTEOSARCOMA: A PHASE 1B STUDY

  Thursday, November 13, 2025
  11:30 AM - 12:30 PM EST

  Disclosure information not submitted.